Alleviating the Metabolic Side Effects of Antipsychotic Medications
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Abdul Khalid
Ballarat Health Services
Principal Investigator - David Barton
Monash Medical Centre
Principal Investigator - Gavin Lambert
Baker IDI Heart & Diabetes Institute
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ballarat Health Service Psychiatric Services
Ballarat, Victoria, Australia
- Monash Medical Centre - Monash Health
Clayton, Victoria, Australia
- Alfred and Baker Medical Unit - Alfred Hospital
Melbourne, Victoria, Australia
- Baker Idi Heart & Diabetes Institute
Melbourne, Victoria, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2012
- Primary completion
- —
- Completion
- —
- Last update posted
- 24 Apr 2019
- Registered enrollment
- 0
- Registry id
- NCT01567124
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.